ContributorsPublishersAdvertisers

Immunotherapy before liver cancer surgery can kill tumor, and likely residual cancer cells

MedicalXpress
 2022-01-20

Cover picture for the articleImmunotherapy given before surgery caused liver cancer tumors to die off in one-third of the patients enrolled in a first-of-its-kind clinical trial, Mount Sinai researchers reported in The Lancet Gastroenterology & Hepatology in January. The phase 2 trial results suggested that the neoadjuvant immunotherapy—therapy given before surgery—may kill not...

medicalxpress.com

Comments / 0

Comments / 0